| 查看: 341 | 回复: 11 | |||
[交流]
【深容SCI写作智能体】Abstract实测
|
|||
|
【深容SCI写作智能体】Abstract实测 如需试用【深容SCI写作智能体】，请联系深容张老师：shenrongagent [https://scioriginal.com] 上月深容推出了【深容SCI写作智能体】的Method，Introduction，Discussion智能体，写作质量非常高，全部真实参考文献，深受用户欢迎。 今天介绍的Abstract写作智能体，功能相对简单，根据用户提供的正文内容，快速起草摘要，同时输出结构式摘要和一体式摘要。 1. 用户输入正文内容： 2. 检索参考同类题材的摘要格式： 3. 输出结果Abstract。 智能体的写作质量非常高： (1) Structured ABSTRACT 1) Background Signal Transducer and Activator of Transcription 2 (STAT2) is well-known for its role in type I interferon (IFN-I) signaling, which is generally considered tumor-suppressive. However, its direct role in cancer, particularly colorectal cancer (CRC), remains underexplored. Given the critical involvement of immune and cytokine networks in CRC progression, elucidating STAT2's contribution is essential. 2) Methods We analyzed TCGA-COAD datasets to assess STAT2 and IFNAR1 expression and patient survival. Human HCT116 and murine MC38 cell lines with STAT2 or IFNAR1 knockouts were generated using CRISPR\/Cas9 technology. Cell proliferation was measured in vitro using the CellTiter 96 assay. In vivo tumor growth was evaluated by subcutaneous injection of knockout and control cells into immunodeficient or immunocompetent mice. Western blot and qPCR analyses were performed to assess downstream signaling and gene expression changes. 3) Results High STAT2 expression in TCGA-COAD tumors correlated with reduced patient survival, independent of IFNAR1 levels. STAT2 deletion impaired cell proliferation and tumor growth in both human and murine models, whereas IFNAR1 deletion did not. STAT2 KO cells exhibited reduced STAT1 activation but enhanced STAT3 phosphorylation, indicating distinct downstream signaling effects compared to IFNAR1 KO cells. These findings suggest that STAT2 promotes tumorigenicity through mechanisms distinct from canonical IFN-I signaling. 4) Conclusion Our study reveals that STAT2 functions as a tumor-promoting factor in CRC, acting independently of IFNAR1-mediated IFN-I signaling. Targeting STAT2 or its downstream pathways may offer a novel therapeutic strategy for mitigating CRC progression. --- (2) Integrated ABSTRACT Signal Transducer and Activator of Transcription 2 (STAT2) is a key mediator of type I interferon (IFN-I) signaling, traditionally viewed as tumor-suppressive. However, its direct role in colorectal cancer (CRC) remains poorly defined, despite the critical influence of immune and cytokine networks on disease progression. To address this gap, we analyzed TCGA-COAD datasets and found that high STAT2 expression in CRC tumors correlated with reduced patient survival, independent of IFNAR1 levels. Using CRISPR\/Cas9 technology, we generated human HCT116 and murine MC38 cell lines with STAT2 or IFNAR1 knockouts. In vitro cell proliferation assays demonstrated that STAT2 deletion significantly impaired growth, whereas IFNAR1 deletion had no effect. In vivo studies in immunodeficient and immunocompetent mice confirmed that STAT2 KO cells formed smaller tumors compared to controls, while IFNAR1 KO cells did not differ significantly from wild-type cells. Western blot and qPCR analyses revealed that STAT2 deletion reduced STAT1 activation but enhanced STAT3 phosphorylation, indicating distinct downstream signaling effects compared to IFNAR1 KO cells. These findings suggest that STAT2 promotes tumorigenicity through mechanisms independent of canonical IFN-I signaling. Our study highlights STAT2 as a potential therapeutic target in CRC, offering new avenues for mitigating disease progression by targeting its pro-tumorigenic pathways. 以上这篇Abstract起草时间仅00:01:35 【深容SCI写作智能体】包括四大模块：Method智能体、Introduction智能体、Discussion智能体、Abstract智能体。 如需试用智能体，请徽售联系深容张老师：shenrongagent [https://scioriginal.com] #SCI论文 #科研 #实验 #博士 #投稿     |
回复此楼» 猜你喜欢
化工学硕294分，求导师收留
已经有29人回复
-
求调剂
已经有10人回复
-
考研求调剂
已经有13人回复
-
求调剂
已经有3人回复
-
人工智能320调剂08工类还有机会吗
已经有17人回复
-
考研英一数一338分
已经有10人回复
-
求助调剂，跨调
已经有15人回复
-
085600材料与化工329分求调剂
已经有20人回复
-
085600材料与化工349分求调剂
已经有15人回复
-
求调剂
已经有13人回复
» 抢金币啦！回帖就可以得到:
-
上海交通大学-宁波东方理工大学联培博士2026年秋季招生
+1/85
-
河南师范大学材料学院招生调剂生
+2/40
-
中医药广东省实验生物成像团队调剂信息
+1/38
-
中新绿色科技研究院（山东济南）招收机械设计方向实习生
+1/38
-
北京理工大学（珠海）招收人工智能方向26级博士
+1/21
-
江苏师范大学招收化学及材料专业研究生
+1/17
-
大连工业大学 高分子材料 接收考研调剂
+1/16
-
哈尔滨工业大学（深圳）赵怡潞课题组诚招博士后、博士生
+1/11
-
重庆三峡科技大学物理电子学、场波专业接收调剂，考数二可调，系统开至4月10日
+1/9
-
煤炭科学研究总院矿山新材料研究院员工博士后招聘
+1/9
-
佛山大学 动物科技学院 畜牧 欢迎广大学子报考！调剂名额若干
+1/9
-
广东石油化工学院刘诗咏教授团队化学化工、材料科学等方向尚有调剂名额
+1/8
-
广东省环境科学研究院招聘【新污染物】研究方向【博士】一名
+1/8
-
华北理工大学-化学工程学院招收材料/化学/化工/环境专业硕士
+1/7
-
深圳理工大学李进课题组招收科研助理/访问学生
+1/7
-
西京学院土木调剂
+1/5
-
湖北师范大学2026硕士调剂 物理 光学 电子 材料相关专业
+1/5
-
延安大学化学与化工学院接收化学专业调剂生，4月11日下午复试（工科、理学均可调剂）
+5/5
-
中山大学课题组招实习生有机合成经验优先
+1/3
-
福建理工大学材料学院学硕专业代码08开头还有调剂名额
+1/2
简单回复
夏末末872楼
2026-01-11 18:20
回复
pheiphei2025(金币+1): 谢谢参与
1 发自小木虫手机客户端
2026-01-11 18:31
回复
jiaoxg4楼
2026-01-11 18:39
回复
pheiphei2025(金币+1): 谢谢参与
tfang5楼
2026-01-11 18:42
回复
pheiphei2025(金币+1): 谢谢参与
2026-01-11 18:51
回复
pheiphei2025(金币+1): 谢谢参与
2026-01-11 19:04
回复
toppaper8楼
2026-01-11 20:07
回复
XG-WUST9楼
2026-01-11 21:35
回复
pheiphei2025(金币+1): 谢谢参与
up 发自小木虫IOS客户端
psylhh10楼
2026-01-11 22:21
回复
pheiphei2025(金币+1): 谢谢参与
庚辰辛丑11楼
2026-01-12 07:28
回复
pheiphei2025(金币+1): 谢谢参与
afit88812楼
2026-01-12 11:17
回复
